Skip to content
Screener

Absci Corporation ABSI Retained Earnings

Retained Earnings at other companies

Schrodinger logo
SchrodingerSDGR
-$682.86M-8.6%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$2.32B-28.7%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-$1.2B-17.6%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$128.07M-450%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$825.44M-3.4%
Assembly Biosciences logo
Assembly BiosciencesASMB
-$841.13M-0.8%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.41B+235%
Enterprise value$1.4B+279%
P/S765.8×+664×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:24 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001672688-26-000088
(In thousands, except for share and per share data)March 31, 2026December 31, 2025
STOCKHOLDERS' EQUITY
Preferred stock
Common stock1515
Additional paid-in capital826,035813,627
Accumulated deficit(654,383)(624,784)
Accumulated other comprehensive income304591
TOTAL STOCKHOLDERS' EQUITY171,971189,449
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$195,593$216,297

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's retained earnings?
Absci Corporation (ABSI) reported retained earnings of -$654.38M in Q1 2026.
How has Absci Corporation's retained earnings changed year-over-year?
Absci Corporation's retained earnings decreased by 22.1% year-over-year, from -$535.95M to -$654.38M.
What is the long-term trend for Absci Corporation's retained earnings?
Over 5 years (2020 to 2025), Absci Corporation's retained earnings has grown at a 47.3% compound annual growth rate (CAGR), from -$90.07M to -$624.78M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about Absci Corporation's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude